Status:
RECRUITING
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
Lead Sponsor:
Lovisenberg Diakonale Hospital
Collaborating Sponsors:
Haukeland University Hospital
Sykehuset Telemark
Conditions:
Arthroplasty, Replacement, Shoulder
Shoulder Osteoarthritis
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shou...
Detailed Description
Many studies have showed pain relief and improvement in shoulder function following reverse shoulder arthroplasty (RSA), but medialization of the centre of rotation (COR) in RSA may cause complication...
Eligibility Criteria
Inclusion
- Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
- Able to read or write Norwegian
Exclusion
- Severe osteoporosis
- Osteonecrosis of the humeral head
- Dementia
- Poor deltoid function
- Revision surgery
- ASA IV
- Suspected chronic infection
- Acute fracture
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2033
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06025331
Start Date
September 15 2023
End Date
August 1 2033
Last Update
November 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sykehuset Telemark HF
Skien, Telemark, Norway, 3710
2
Lovisenberg Diaconal Hospital
Oslo, Norway, 0456